Circulating Nonphosphorylated Carboxylated Matrix Gla Protein Predicts Survival in ESRD
Open Access
- 1 February 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 22 (2), 387-395
- https://doi.org/10.1681/asn.2010040339
Abstract
The mechanisms for vascular calcification and its associated cardiovascular mortality in patients with ESRD are not completely understood. Dialysis patients exhibit profound vitamin K deficiency, which may impair carboxylation of the calcification inhibitor matrix gla protein (MGP). Here, we tested whether distinct circulating inactive vitamin K–dependent proteins associate with all-cause or cardiovascular mortality. We observed higher levels of both desphospho-uncarboxylated MGP (dp-ucMGP) and desphospho-carboxylated MGP (dp-cMGP) among 188 hemodialysis patients compared with 98 age-matched subjects with normal renal function. Levels of dp-ucMGP correlated with those of protein induced by vitamin K absence II (PIVKA-II; r = 0.62, P < 0.0001). We found increased PIVKA-II levels in 121 (64%) dialysis patients, indicating pronounced vitamin K deficiency. Kaplan-Meier analysis showed that patients with low levels of dp-cMGP had an increased risk for all-cause and cardiovascular mortality. Multivariable Cox regression confirmed that low levels of dp-cMGP increase mortality risk (all-cause: HR, 2.2; 95% CI, 1.1 to 4.3; cardiovascular: HR, 2.7; 95% CI, 1.2 to 6.2). Furthermore, patients with higher vascular calcification scores showed lower levels of dp-cMGP. In 17 hemodialysis patients, daily supplementation with vitamin K2 for 6 weeks reduced dp-ucMGP levels by 27% (P = 0.003) but did not affect dp-cMGP levels. In conclusion, the majority of dialysis patients exhibit pronounced vitamin K deficiency. Lower levels of circulating dp-cMGP may serve as a predictor of mortality in dialysis patients. Whether vitamin K supplementation improves outcomes requires further study.Keywords
This publication has 34 references indexed in Scilit:
- The Circulating Inactive Form of Matrix Gla Protein Is a Surrogate Marker for Vascular Calcification in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Vitamins K and D Status in Stages 3–5 Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial FibrillationJournal of the American Society of Nephrology, 2009
- Vitamin K supplementation and progression of coronary artery calcium in older men and womenThe American Journal of Clinical Nutrition, 2009
- Dialysis Accelerates Medial Vascular Calcification in Part by Triggering Smooth Muscle Cell ApoptosisCirculation, 2008
- The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular CalcificationJournal of Vascular Research, 2008
- VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Inhibitors of Calcification in Blood and UrineSeminars in Dialysis, 2007
- Relation of Oral Anticoagulation to Cardiac Valvular and Coronary Calcium Assessed by Multislice Spiral Computed TomographyThe American Journal of Cardiology, 2005
- Patient mortality and survival. United States Renal Data SystemAmerican Journal of Kidney Diseases, 1998
- Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA proteinNature, 1997